Current Status of Tranexamic Acid in Hyperacute Treatment of Intracerebral Hemorrhage.
作者信息
Philips Atul, Pandian Jeyaraj Durai
机构信息
Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Neurology, Christian Medical College, Ludhiana, Punjab, India.
出版信息
Ann Indian Acad Neurol. 2024 Jul 1;27(4):358-363. doi: 10.4103/aian.aian_435_24. Epub 2024 Aug 23.
Abstract
摘要
相似文献
1
Current Status of Tranexamic Acid in Hyperacute Treatment of Intracerebral Hemorrhage.氨甲环酸在脑出血超急性期治疗中的现状
Ann Indian Acad Neurol. 2024 Jul 1;27(4):358-363. doi: 10.4103/aian.aian_435_24. Epub 2024 Aug 23.
2
Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.静脉注射氨甲环酸治疗超急性原发性脑出血：一项随机、安慰剂对照试验的方案
Int J Stroke. 2016 Aug;11(6):683-94. doi: 10.1177/1747493016641960. Epub 2016 Apr 5.
3
Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign.氨甲环酸预防有或无点状征的脑出血患者血肿扩大
Stroke. 2021 Aug;52(8):2629-2636. doi: 10.1161/STROKEAHA.120.032426. Epub 2021 May 18.
4
Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.氨甲环酸改善自发性脑出血成人的功能状态：TICH-2 RCT。
Health Technol Assess. 2019 Jul;23(35):1-48. doi: 10.3310/hta23350.
5
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.氨甲环酸治疗超急性原发性脑出血（TICH-2）：一项国际随机、安慰剂对照、3 期优效性试验。
Lancet. 2018 May 26;391(10135):2107-2115. doi: 10.1016/S0140-6736(18)31033-X. Epub 2018 May 16.
6
The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.斑点征与氨甲环酸预防脑出血扩大——澳大拉西亚试验（STOP-AUST）：一项II期随机、安慰剂对照、双盲、多中心试验的方案
Int J Stroke. 2014 Jun;9(4):519-24. doi: 10.1111/ijs.12132. Epub 2013 Aug 26.
7
The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data From 121 Surgically Treated Participants From the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial.氨甲环酸对自发性脑出血神经外科干预的影响：来自氨甲环酸脑出血-2 随机对照试验 121 例手术治疗参与者的数据。
Neurosurgery. 2024 Sep 1;95(3):605-616. doi: 10.1227/neu.0000000000002961. Epub 2024 May 24.
8
Effect of Tranexamic Acid Administration on Remote Cerebral Ischemic Lesions in Acute Spontaneous Intracerebral Hemorrhage: A Substudy of a Randomized Clinical Trial.氨甲环酸给药对急性自发性脑出血后远隔脑缺血损伤的影响：一项随机临床试验的亚研究。
JAMA Neurol. 2022 May 1;79(5):468-477. doi: 10.1001/jamaneurol.2022.0217.
9
Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: Rationale and design.氨甲环酸用于斑点征试验预测的急性脑出血扩大：原理与设计
Int J Stroke. 2017 Apr;12(3):326-331. doi: 10.1177/1747493017694394. Epub 2017 Jan 1.
10
Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial.氨甲环酸对入院扫描有或无斑点征的脑出血患者血肿进展的预防作用：TICH-2试验一项预先指定的亚研究的统计分析计划
BMC Res Notes. 2018 Jun 13;11(1):379. doi: 10.1186/s13104-018-3481-8.
本文引用的文献
1
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.氨甲环酸对比安慰剂治疗发病 2 小时内的脑出血患者（STOP-MSU）：一项国际、双盲、随机、2 期试验。
Lancet Neurol. 2024 Jun;23(6):577-587. doi: 10.1016/S1474-4422(24)00128-5. Epub 2024 Apr 20.
2
Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage.早期微创清除脑出血的试验。
N Engl J Med. 2024 Apr 11;390(14):1277-1289. doi: 10.1056/NEJMoa2308440.
3
The burden, risk factors and unique etiologies of stroke in South-East Asia Region (SEAR).东南亚地区（SEAR）中风的负担、风险因素及独特病因。
Lancet Reg Health Southeast Asia. 2023 Oct 9;17:100290. doi: 10.1016/j.lansea.2023.100290. eCollection 2023 Oct.
4
Effects of blood pressure and tranexamic acid in spontaneous intracerebral haemorrhage: a secondary analysis of a large randomised controlled trial.血压与氨甲环酸对自发性脑出血的影响：一项大型随机对照试验的二次分析
BMJ Neurol Open. 2023 Jun 12;5(1):e000423. doi: 10.1136/bmjno-2023-000423. eCollection 2023.
5
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.颅内出血降压强化治疗试验 3 期（INTERACT3）：一项国际性、梯次楔形簇随机对照试验。
Lancet. 2023 Jul 1;402(10395):27-40. doi: 10.1016/S0140-6736(23)00806-1. Epub 2023 May 25.
6
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.2022年自发性脑出血患者管理指南：美国心脏协会/美国中风协会指南
Stroke. 2022 Jul;53(7):e282-e361. doi: 10.1161/STR.0000000000000407. Epub 2022 May 17.
7
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.1990—2019年全球、区域和国家的卒中负担及其风险因素：全球疾病负担研究2019的系统分析
Lancet Neurol. 2021 Oct;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0. Epub 2021 Sep 3.
8
Haemostatic therapy in spontaneous intracerebral haemorrhage patients with high-risk of haematoma expansion by CT marker: a systematic review and meta-analysis of randomised trials.CT 标志物预测血肿扩大风险较高的自发性脑出血患者的止血治疗：随机试验的系统评价和荟萃分析。
Stroke Vasc Neurol. 2021 Jun;6(2):170-179. doi: 10.1136/svn-2021-000941. Epub 2021 Apr 1.
9
Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial.基于影像学评估的急性脑出血增长用氨甲环酸（TRAIGE）：一项多中心、随机、安慰剂对照试验。
Stroke Vasc Neurol. 2021 Jun;6(2):160-169. doi: 10.1136/svn-2021-000942. Epub 2021 Apr 1.
10
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.氨甲环酸治疗脑出血患者（STOP-AUST）：一项多中心、随机、安慰剂对照、2 期临床试验。
Lancet Neurol. 2020 Dec;19(12):980-987. doi: 10.1016/S1474-4422(20)30369-0. Epub 2020 Oct 28.
Zotero 插件